[S18] Symposium 18
Undiagnosed intractable disease: Therapeutic and preventive strategy for kernicterus of preterm infants

Sat. Jun 17, 2017 8:30 AM - 10:30 AM Room No.8 (10F Conference Room 1006-1007)

Chair:Akihisa Okumura(Department of Pediatrics, Aichi Medical University, Nagakute, Japan), Hiroshi Arai(Department of Pediatric Neurology, Bobath Memorial Hospital, Osaka, Japan)

[Aim]
The clinical picture of cerebral palsy changes along with time. With the improved survival rate of preterm infants, periventricular leukomalacia (PVL) attracted an attention in the 1990 's. However, in the 21st century, PVL has declined and kernicterus of preterm infants is increasing. Brain lesions of kernicterus are not easy to read unlike PVL. Therefore, kernicterus tends to remain undiagnosed. This symposium aims to disseminate recent findings of kernicterus of preterm infants, introduce the present state of preventive and therapeutic methods, and broadly share teem.

+Add all to schedule

[S18-1] 1）Current status of kernicterus of preterm infants and its diagnosis

^○AKIHISA OKUMURA (Department of Pediatrics, Aichi Medical University, Nagakute, Japan)

[S18-2] 2）Neurological features and MR images of children with kernicterus in infancy and childhood

^○YUKIHIRO KITAI, HIROSHI ARAI, SATORI HIRAI, Kayo Ohmura, Kaeko Ogura (The department of pediatric neurology, Morinomiya Hospital, Osaka, Japan)

[S18-3] 3）Therapy

^○SATORI HIRAI, Yukihiro Kitai, Kaeko Ogura, Kayo Ohmura, Hiroshi Arai (Morinomiya Hospital, Osaka, Japan)

[S18-4] 4）A new proposed hyperbilirubinemia management and treatment criteria for preterm infants

^○ICHIRO MORIOKA (Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan)